Literature DB >> 27245698

Mechanism of gene-specificity of oncogenic regulators.

Panagiotis Moulos1, Michalis E Sarris1, Iannis Talianidis1.   

Abstract

Keywords:  Smyd3; liver cancer; transcription regulation

Mesh：

Substances：

Year:  2016        PMID： 27245698      PMCID： PMC5004681          DOI： 10.1080/15384101.2016.1191254

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

1.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

2.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

Review 3.  Context-specific regulation of cancer epigenomes by histone and transcription factor methylation.

Authors:  M Sarris; K Nikolaou; I Talianidis
Journal:  Oncogene       Date:  2013-03-18       Impact factor: 9.867

4.  SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer.

Authors:  Pawel K Mazur; Nicolas Reynoird; Purvesh Khatri; Pascal W T C Jansen; Alex W Wilkinson; Shichong Liu; Olena Barbash; Glenn S Van Aller; Michael Huddleston; Dashyant Dhanak; Peter J Tummino; Ryan G Kruger; Benjamin A Garcia; Atul J Butte; Michiel Vermeulen; Julien Sage; Or Gozani
Journal:  Nature       Date:  2014-05-21       Impact factor: 49.962

5.  Spontaneous development of hepatocellular carcinoma with cancer stem cell properties in PR-SET7-deficient livers.

Authors:  Kostas C Nikolaou; Panagiotis Moulos; George Chalepakis; Pantelis Hatzis; Hisanobu Oda; Danny Reinberg; Iannis Talianidis
Journal:  EMBO J       Date:  2014-12-16       Impact factor: 11.598

6.  Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development.

Authors:  Michalis E Sarris; Panagiotis Moulos; Anna Haroniti; Antonis Giakountis; Iannis Talianidis
Journal:  Cancer Cell       Date:  2016-02-18       Impact factor: 31.743
  6 in total
  2 in total

1.  Analysis of SET and MYND Domain-Containing Protein 3 (SMYD3) Expression in Gallbladder Cancer: a Pilot Study.

Authors:  Pushkar Chandra; Ruhi Dixit; Arvind Pratap; Suman Mishra; Rajnikant Mishra; Vijay Kumar Shukla
Journal:  Indian J Surg Oncol       Date:  2020-07-11

2.  SMYD3-PARP16 axis accelerates unfolded protein response and mediates neointima formation.

Authors:  Fen Long; Di Yang; Jinghua Wang; Qing Wang; Ting Ni; Gang Wei; Yizhun Zhu; Xinhua Liu
Journal:  Acta Pharm Sin B       Date:  2020-12-15       Impact factor: 11.413
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.